Abstract
The present study was designed to compare the cardiotoxicity of two very commonly used anti-diabetic drugs namely pioglitazone (Pio) and metformin (Met); and to study the effects of curcumin (Curc) against these drug-induced cardiotoxicity. Curc, being an anti-oxidant molecule and having cardio-protective potential, can have promising synergistic effects in reducing the cardiac stress induced by anti-diabetic therapies. Various dose and time-dependent cell viability and oxidative stress assays were conducted to study cardiotoxic side-effects and Curc-mediated effects in cardiomyoblasts. Effects of Curc were also studied in hyperglycaemia induced cardiac stress in the presence of drugs. Quantitative assays for cell growth, reactive oxygen species (ROS) generation, lipid peroxidation and mitochondrial permeability followed by anti-oxidant enzymes and caspases activity assays were done to study the mechanism of action of the induced cardiotoxicity. Significant dose and time mediated deleterious effects of Pio and Met were witnessed. Oxidative stress studies showed a remarkable increase in ROS with increasing dose of anti-diabetic drugs. Increased caspase activity and altered mitochondrial integrity were also witnessed in presence of Met and Pio in cardiomyoblasts. These alterations were found to be significantly reduced when treated with Curc simultaneously. The study confirms that Met and Pio exert toxic effects on cardiac cells by generating oxidative stress. Curc, being an anti-oxidative molecule, can suppress this effect and, therefore, can be used as a supplement with anti-diabetic drugs to suppress the induced cardiac stress.
This is a preview of subscription content,
to check access.




















Similar content being viewed by others
References
Agarwal AA, Jadhav PR, Deshmukh YA et al (2014) Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm 5(3):79–83
Aggarwal BB, Sundaram C, Malani N et al (2006) Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1–75
American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(Suppl 1):S62–S67. https://doi.org/10.2337/dc09-S062
An D, Kewalramani G, Chan JK et al (2006) Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3. Diabetologia 49(9):2174–2184
Anand P, Kunnumakkara AB, Newman RA et al (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807–818
Anfossi G, Russo I, Bonomo K et al (2011) The cardiovascular effects of metformin: further reasons to consider an old drug as a cornerstone in the therapy of type 2 diabetes mellitus. Curr Vasc Pharmacol 8(3):327–337
Asensio-Lopez MC, Lax A, Pascual-Figal DA et al (2011) Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system. Free Radic Biol Med 51:1861–1871
Averill-Bates D, Grondin M, Ouellet F (2018) Activation of apoptosis signaling pathways by reactive oxygen species. Cryobiology 80:170
Bahtiyar G, Gutterman D, Lebovitz H (2016) Heart failure: a major cardiovascular complication of diabetes mellitus. Curr Diab Rep 16(11):116
Bugger H, Abel ED (2014) Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57(4):660–671
Carter WO, Narayanan PK, Robinson JP (1994) Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 55(2):253–258
Chen L, Magliano DJ, Zimmet PZ (2012) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 8:228–236
Cummings BS, Schnellmann RG (2012) Measurement of cell death in mammalian cells. Curr Protoc Pharmacol 56(1):8–12
Deavall DG, Martin EA, Horner JM et al (2012) Drug-induced oxidative stress and toxicity. J Toxicol 2012:645460
El Messaoudi S, Rongen GA, de Boer RA, Riksen NP (2011) The cardioprotective effects of metformin. Curr Opin Lipidol 22(6):445–453
Foretz M, Guigas B, Bertrand L et al (2014) Metformin: from mechanisms of action to therapies. Cell Metab 20(6):953–966
Fulda S, Gorman AM, Hori O et al (2010) Cellular stress responses: cell survival and Cell death. Int J Cell Biol 2010:1–23
Gejl M, Starup-Linde J, Scheel-Thomsen J et al (2015) Risk of cardiovascular disease: the effects of diabetes and anti-diabetic drugs—a nested case–control study. Int J Cardiol 178:292–296
Halliwell B, Chirico S (1993) Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 57:715–725
Hosseinzadeh L, Behravan J, Mosaffa F et al (2011) Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species. Food Chem Toxicol 49(5):1102–1109
Hostalek U, Gwilt M, Hildemann S (2015) Therapeutic use of metformin in pre diabetes and diabetes prevention. Drugs 75(10):1071–1094
Huynh K, Bernardo BC, McMullen JR et al (2014) Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther 142(3):375–415
Iannello S, Milazzo P, Bordonaro F et al (2005) Effect of in vitro glucose and diabetic hyperglycemia on mouse kidney protein synthesis: relevance to diabetic microangiopathy. Med Gen Med 7(3):1
Jain A, Rani V (2018) Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts. Mol Cell Biochem 442(1–2):81–96
Kloppel G, Lohr M, Habich K et al (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Syn Pathol Res 4(2):110–125
Kobayashi S, Xu X, Chen K et al (2012) Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury. Autophagy 8(4):577–592
Kohli S, Chhabra A, Jaiswal A et al (2013) Curcumin suppresses gelatinase B mediated norepinephrine induced stress in H9c2 cardiomyocytes. PLoS One 8:1–12
Kunwar A, Barik A, Priyadarsini KI et al (2007) Absorption and fluorescence studies of curcumin bound to liposome and living cells. BARC Newslett 285:213
Leiber DC, Guengerich FP (2005) Elucidating mechanism of drug induced toxicity. Nat Rev Drug Discov 4:410–420
Lincon VJ, Walsh ML, Chen LB (1980) Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci USA 77(2):990–994
Luo C-S, Liang J-R, Lin Q et al (2014) Cellular responses associated with ROS production and cell fate decision in early stress response to iron limitation in the diatom Thalassiosira pseudonana. J Proteome Res 13(12):5510–5523
Mandavia CH, Aroor AR, DeMarco VG et al (2013) Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. Life Sci 92(11):601–608
Messaoudi SE, Rongen GA, De Boer RA et al (2011) The cardioprotective effects of metformin. Curr Opin Lipidol 22(6):445–453
Mikhail N (2008) Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential. Vasc Health Risk Manag 4(6):1221–1227
Miki T, Yuda S, Kouzu H et al (2013) Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev 18(2):149–166
Mittler R (2017) ROS are good. Trends Plant Sci 22(1):11–19
Mohan V, Bedi S, Unnikrishnan R, Sahay BK et al (2012) Pioglitazone—where do we stand in India? JAPI 60(1):68–70
Nguyen HN, Ha PT, Sao Nguyen A et al (2016) Curcumin as fluorescent probe for directly monitoring in vitro uptake of curcumin combined paclitaxel loaded PLA-TPGS nanoparticles. Adv Nat Sci Nanosci Nanotechnol 7(2):025001
Nicholls DG (2012) Fluorescence measurement of mitochondrial membrane potential changes in cultured cells. Methods Mol Biol 10:119–133
Nowotny K, Jung T, Hohn A et al (2015) Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5(1):194–222
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Pai SA, Kshirsagar NA (2016) Pioglitazone utilization, efficacy and safety in Indian type 2 diabetic patients: a systematic review and comparison with European Medicines Agency Assessment Report. Indian J Med Res 144(5):672–681
Patel SS, Goyal RK (2011) Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacogn Res 3(4):239–245
Pogatsa G (1996) What kind of cardiovascular alterations could be influenced positively by oral antidiabetic agents? Diabetes Res Clin Pract 31:S27–SS31
Prabst K, Engelhardt H, Ringgeler S et al (2017) Basic colorimetric proliferation assays: MTT, WST, and resazurin. Methods Mol Biol 1601:1–17
Rakovac I, Jeitler K, Gfrerer RJ et al (2005) Patients with type 2 diabetes treated with metformin: prevalence of contraindications and their correlation with discontinuation. Diabet Med 22(5):662–664
Rudy E (2007) Drugs that induce heart failure: an overview (part-1). Drug Ther Top ADR Focus 36(7):31–34
Ryter SW, Kim HP, Hoetzel A et al (2007) Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 9(1):49–89
Santulli G (2013) Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. The current epidemiology of CV disease. J Cardiovasc Dis Res 1(1):1
Selvin E, Steffes MW, Zhu H et al (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800–811
Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14
Smith U (2001) Pioglitazone: mechanism of action. Int J Clin Pract Suppl 121:13–18
Somparn P, Phisalaphong C, Nakornchai S et al (2007) Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 30(1):74–78
Spiller HA, Quadrani DA (2004) Toxic effects from metformin exposure. Ann Pharmacother 38(5):776–780
Sterba M, Popelova O, Vavrova A et al (2013) Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antioxid Redox Signal 18(8):899–929
Suzuki T (2010) Significance and limitation of changing the lifestyle among the elderly—strategies on the prevention of lifestyle-related diseases and long-term care state. Nihon Rinsho 68(5):953–968
Tanne JH (2007) FDA places “black box” warning on anti diabetes drugs. BMJ 334(7606):1237
Umadevi S, Gopi V, Simna SP et al (2012) Studies on the cardio protective role of gallic acid against AGE-induced cell proliferation and oxidative stress in H9c2 (2-1) cells. Cardiovasc Toxicol 12:304–311
Varga ZV, Ferdinandy P, Liaudet L (2015) Drug-induced mitochondrial dysfunction and cardiotoxicity. Am J Physiol Heart Circ Physiol 309(9):H1453–H1467
Watkins S, Borthwick G, Arthur H (2011) The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim 47:125–131
Wongcharoen W, Phrommintikul A (2009) The protective role of curcumin in cardiovascular diseases. Int J Cardiol 133(2):145–151
Yagi S, Drouart N, Bourgaud F et al (2012) Antioxidant and antiglycation properties of Hydnora johannis roots. S Afr J Bot 84:124–127
Zhou G, Myers R, Li Y et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Investig 108(8):1167–1174
Zordoky BN, El-Kadi AO (2007) H9C2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart. J Pharmacol Toxicol Methods 56:317–322
Acknowledgements
The present work was supported by a research funding granted to Dr. Vibha Rani by the Department of Biotechnology (DBT), Government of India (Ref No.: BT/PR3978/17/766/2011). We acknowledge Jaypee Institute of Information Technology, Deemed to be University and Department of Biotechnology, Govt. of India for providing the infrastructural support and funds, respectively. We would also like to acknowledge Dr. Papia Chowdury, Associate Professor, Department of Physics and Material Science, Jaypee Institute of Information Technology for assisting in spectrofluorometer related studies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest among the authors for the publication of this article.
Additional information
Conference Abstract ID: ICABB-2018/136.
Rights and permissions
About this article
Cite this article
Jain, A., Rani, V. Curcumin-mediated effects on anti-diabetic drug-induced cardiotoxicity. 3 Biotech 8, 399 (2018). https://doi.org/10.1007/s13205-018-1425-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-018-1425-6